Technological Aspects

Micronization is a sophisticated particle engineering technology that reduces APIs to the microscopic scale, typically achieving an average size of less than 10 microns. While its primary biopharmaceutical objective is to enhance bioavailability and therapeutic efficiency by exponentially increasing specific surface area and dissolution rates, its technological impact on formulation manufacturing is equally vital for ensuring product quality and process reliability.

From a technological standpoint, micronization is essential for achieving high levels of content homogeneity. By producing a narrow and uniform particle size distribution, the process significantly decreases segregation effect during downstream handling. This uniformity favors the mixing of components present in very small proportions, ensuring that even low-dose APIs are homogeneously distributed throughout the excipient matrix.

In the development of specialized dosage forms, micronization ensures the syringeability of injectable suspensions, preventing mechanical blockages in fine-gauge needles. It also improves the physical stability of these suspensions by reducing sedimentation rates, which is critical for maintaining dose uniformity. For solid dosage forms, the technique provides unique rheological advantages improving the flowability of challenging materials like needle-like crystals by altering their aspect ratio. Furthermore, micronization improves the functionality of lubricants used during tableting, as the increased surface area of the particles allows for more efficient and uniform lubricant coverage.

By addressing these technological challenges, micronization serves as a critical bridge between raw drug substance and a high-performance drug product.